trial · primary record
Nimorazole
Head and Neck Squamous Cell Carcinoma
| Phase | Phase 3 |
|---|---|
| Status | COMPLETED |
| Sponsor | Unknown |
| Enrolment | 1252 |
| Primary completion | 2024-12 |
| Primary endpoint | Number of participants with locoregional tumour control |
| Registry ID | NCT02661152 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:47:08.430Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT02661152
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.